Monday, November 21, 2016

BRIEF-Oragenics - expects to file an investigational new drug (IND) update and initiate a phase 2 study with AG013 in United States and Europe in early 2017

* Oragenics - expects to file an investigational new drug

(ind) update and initiate a phase 2 study with ag013 in united

states and europe in early 2017

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)